Pfizer Starts Second Phase of Testing New Antiviral COVID-19 Oral Drug in Exposed Adults

WASHINGTON (Sputnik) - Pfizer has started the second phase in the study of its new oral antiviral drug to prevent COVID-19 infection in adults exposed to the novel coronavirus, the company said on Monday.